Is Plasmodium vivax still a paradigm for uncomplicated malaria?;Plasmodium vivax est-il encore le paradigme d'un paludisme simple ?

Medecine et Maladies Infectieuses

Volumn 36, Issue 8, 2006, Pages 406-413

  Picot, S ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Antimalarial drug resistance; Plasmodium vivax; Primaquine; Severe malaria

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; MEFLOQUINE; PRIMAQUINE; TAFENOQUINE;

ANTIBIOTIC RESISTANCE; DRUG MECHANISM; ENDEMIC DISEASE; FEVER; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION PREVENTION; MALARIA; PARASITE TRANSMISSION; PARASITE VIRULENCE; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SHORT SURVEY; SOUTHEAST ASIA; ANIMAL; DISEASE TRANSMISSION; IMMUNOLOGY; INNATE IMMUNITY; PHYSIOLOGY; REVIEW; TRAVEL;

ANIMALS; HUMANS; IMMUNITY, NATURAL; MALARIA, VIVAX; PLASMODIUM VIVAX; TRAVEL;

EID: 33748740898     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2006.06.001     Document Type: Short Survey

References (53)

1. Mendis K., Sian B.J., Marchesini P., and Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. (2001) 97-106
2. Mouchet J., Carnevale P., Coosemans M., Julvez J., Manguin S., Richard-LEnoble D., et al. Biodiversité du paludisme dans le monde (2004), John Libbey eurotext, Montrouge
3. Sattabongkot J., Tsuboi T., Zollner G.E., Sirichaisinthop J., and Cui L. Plasmodium vivax transmission: chances for control?. Trends Parasitol. 20 (2004) 192-198
4. Oh M.D., Shin H., Shin D., Kim U., Lee S., Kim N., et al. Clinical features of vivax malaria. Am. J. Trop. Med. Hyg. 65 (2001) 143-146
5. Singh S.K., Hora R., Belrhali H., Chitnis C.E., and Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439 (2006) 741-744
6. Mu J., Joy D.A., Duan J., Huang Y., Carlton J., Walker J., et al. Host switch leads to emergence of Plasmodium vivax malaria in humans. Mol. Biol. Evol. 22 (2005) 1686-1693
7. Lim C.S., Tazi L., and Ayala F.J. Plasmodium vivax: recent world expansion and genetic identity to Plasmodium simium. Proc. Natl. Acad. Sci. USA 102 (2005) 15523-15528
8. Carter R. Speculations on the origins of Plasmodium vivax malaria. Trends Parasitol. 19 (2003) 214-219
9. Temel T. Malaria from the gap: need for cross-sector co-operation in Azerbaijan. Acta Trop. 89 (2003) 249-259
10. Yeom J.S., Ryu S.H., Oh S., Lee W.J., Kim T.S., Kim K.H., et al. Status of Plasmodium vivax malaria in the republic of Korea during 2001-2003. Am. J. Trop. Med. Hyg. 73 (2005) 604-608
11. Hamedi Y., Nateghpour M., Tan-ariya P., Tiensuwan M., Silachamroon U., and Looreesuwan S. Plasmodium vivax malaria in South-East Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo. Southeast Asian J. Trop. Med. Public Health 33 (2002) 512-518
12. Severine C., Menegon M., Di Luca M., Abdullaev I., Majori G., Razakov S.A., et al. Risk of Plasmodium vivax malaria reintroduction in Uzbekistan: genetic characterization of parasites a status of potential malaria vectors in the Surkhandarya region. Trans. R. Soc. Trop. Med. Hyg. 98 (2004) 585-592
13. Schlagenhauf P. Malaria in Iraq - the pitfalls of Plasmodium vivax prophylaxis. Lancet Infect. Dis. 3 (2003) 460
14. Faraj C., Adlaoui E., Rhajaou M., and Lyagoubi M. Estimation of malaria transmission in high-risk provinces of Morocco. East. Mediterr. Health J. 9 (2003) 542-547
15. Rutar T., Baldomar Salgueiro E.J., and Maguire J.H. Introduced Plasmodium vivax malaria in a Bolivian community at an elevation of 2,300 meters. Am. J. Trop. Med. Hyg. 70 (2004) 15-19
16. Carme B., Lecat J., and Lefebvre P. Malaria in an outbreak zone in Oyapock (French Guiana): incidence of malaria attacks in the American Indian population of Camopi. Med. Trop. 65 (2005) 149-154
17. Carme B. Substantial increase of malaria in inland areas of eastern French Guiana. Trop. Med. Int. Health 10 (2005) 154-159
18. Duarte E.C., Gyorkos T.W., Pang L., and Abrahamowicz M. Epidemiology of malaria in a hypoendemic Brazilian Amazon migrant population: a cohort study. Am. J. Trop. Med. Hyg. 70 (2004) 229-237
19. Nagao Y., Dachlan Y.P., Soedarto, Hidajati S., Yotopranoto S., Kusmartisnawati, et al. Distribution of two species of malaria, Plasmodium falciparum and Plasmodium vivax, on Lombok Island, Indonesia. Southeast Asian J. Trop. Med. Public Health 34 (2003) 495-500
20. Krisin, Basri H., Fryauff D.J., Barcus M.J., Bangs M.J., Ayomi E., et al. Malaria in a cohort of Javanese migrants to Indonesian Papua. Ann. Trop. Med. Parasitol. 97 (2003) 543-556
21. Sumawinata I.W., Bernadeta, Leksana B., Sutamihardja A., Purnomo, Subianto B., et al. Very high-risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Indonesian Papua. Am. J. Trop. Med. Hyg. 68 (2003) 416-420
22. Torres K.L., Figueiredo D.V., Zalis M.G., Daniel-Ribeiro C.T., Alecrim W., and Ferreira-da-Cruz Mde F. Standardization of a very specific and sensitive single PCR for detection of Plasmodium vivax in low parasitised individuals and its usefulness for screening blood donors. Parasitol. Res. 98 (2006) 519-524
23. de Monbrison F., Angei C., Staal A., Kaiser K., and Picot S. Simultaneous identification of the four human Plasmodium species and quantification of Plasmodium DNA load in human blood by real-time polymerase chain reaction. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 387-390
24. Snounou G., and White N.J. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol. 20 (2004) 333-339
25. Elliott J.H., O'Brien D., Leder K., Kitchener S., Schwartz E., Weld L., et al. Imported Plasmodium vivax malaria: demographic and clinical features in non-immune traverlers. J. Travel Med. 11 (2004) 213-219
26. Ridley R.G. Chemotherapeutic hope on the horizon for Plasmodium vivax malaria. Proc. Natl. Acad. Sci. USA 99 (2002) 13362-13364
27. Kochar D.K., Saxena V., Singh N., Kochar S.K., Kumar S.V., and Das A. Plasmodium vivax malaria. Emerging Infect. Dis. 11 (2005) 132-134
28. Choi H.J., Lee S.Y., Yang H., and Bang J.K. Retinal haemorrhage in vivax malaria. Trans. Soc. Royal Soc. Trop. Med. Hyg. 98 (2004) 387-389
29. Lawn S.D., Krishna S., Jarvis J.N., Joet T., and Macallan D.C. Case reports: pernicious complications of benign tertian malaria (2003) 551-553 (97)
30. Tanios M.A., Kogelman L., McGovern B., and Hassoun P.M. Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit. Care Med. 29 (2001) 665-667
31. Idro R., Jenkins N.E., and Newton C.R. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 4 (2005) 827-840
32. Munteis E., Mellibovsky L., Marquez M.A., Minguez S., Vazquez E., and Diez A. Pulmonary involvement in a case of Plasmodium vivax malaria. Chest 111 (1997) 834-835
33. Karunaweera N.D., Wijesekera S.K., Wanasekera D., Mendis K.N., and Carter R. The paroxysm of Plasmodium vivax malaria. Trends Parasitol. 19 (2003) 188-193
34. Pukrittayakamee S., Imwong M., Looareesuwan S., and White N.J. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop. 89 (2004) 351-356
35. Baird J.K. Chloroquine resistance in Plasmodium vivax. Antimicrob. Agents Chemother. 48 (2004) 4075-4083
36. Nicolas X., Granier H., Laborde J.P., Talarmin F., and Klotz F. Plasmodium vivax : actualités thérapeutiques. Presse Med. 30 (2001) 767-771
37. Baird J.K., and Rieckmann K.H. Can primaquine therapy for vivax malaria be improved?. Trends Parasitol. 19 (2003) 115-120
38. Kitchener S., Nasveld P., Bennett S., and Torresi J. Adequate primaquine for vivax malaria. J. Travel Med. 12 (2005) 133-135
39. Frank J.E. Diagnosis and management of G6PD deficiency. Am. Fam. Physician 72 (2005) 1277-1282
40. Jalloh A., Tantular I.S., Pusarawati S., Kawilarang A.P., Kerong H., Lin K., et al. Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit. Trop. Med & Intern. Health 9 (2004) 615-623
41. Walsh D.S., Wilairatana P., Tang D.B., Heppner D.G., Brewer T.G., Krudsood S., et al. Randomized trial of 3-dose regimens of tafenoquine (WR238605) vs low-dose primaquine for preventing Plasmodium vivax malaria relapse. CID 39 (2004) 1095-1103
42. Nasveld P., and Kitchener S. Treatment of acute vivax malaria with tafenoquine. Trans. R. Soc. Trop. Med. Hyg. 99 (2005) 2-5
43. World Health Organization. Guidelines for the treatment of malaria. Genève: WHO. In press 2006, 87p. - WHO/HTM/MAL/2006.1108.
44. Maguire J.D., Krisin, Marwoto H., Richie T.L., Fryauff D.J., and Baird J.K. Mefloquine is HIGHLY efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. Clin. Infect. Dis. 15 42 (2006) 1067-1072
45. Hastings M.D., and Sibley C.H. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax. Proc. Natl. Acad. Sci. USA 99 (2002) 13137-13141
46. Picot S. Methods to study drug resistance of Plasmodium falciparum to quinolines. Med Trop 61 (2001) 15-20
47. Kosaisavee V., Suwanarusk R., Nosten F., Kyle D.E., Barrends M., Jones J., et al. Plasmodium vivax : isotopic, Picogreen, and microscopic assays for measuring chloroquine sensitivty in fresh and cryopreserved isolates. Exp. Parasitol. (2006) (Epub ahead of print)
48. Fryauff D.J., Fryauff D.J., Baird J.K., Candradikusuma D., Masbar S., Sutamihardja M.A., et al. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and Plasmodium vivax in Lombok, Indonesia. Am. J. Trop. Med. Hyg. 56 (1997) 241-244
49. Baird J.K., et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 56 (1997) 627-631
50. Brega S., de Monbrison F., Severini C., Udomsangpetch R., Sutanto I., Ruckert P., et al. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob. Agents Chemother. 48 (2004) 2581-2587
51. Brega S., Meslin B., de Monbrison F., Severini C., Gradoni L., Udomsangpetch R., et al. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. J. Infect. Dis. 191 (2005) 272-277
52. Povinelli L., Monson T.A., Fox B.C., Parise M.E., Morrisey J.M., and Vaidya A.B. Plasmodium vivax malaria in spite of atovaquone/proguanil (malarone) prophylaxis. J. Travel Med. 10 (2003) 353-355
53. Picot S., Brega S., Jérôme P., Velut G., de Monbrison F., Cheminel V., et al. Absence of nucleotide polymorphism in a Plasmodium vivax multidrug resistance gene after failure of mefloquine prophylxis in French Guyana. Trans. R. Soc. Trop. Med. Hyg. 99 (2005) 234-237